Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
22
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Khan Amin | Other | 3 | $0 | $0 | 2024-02-19 |
| Shiver John W. | Other | 10 | $0 | $0 | 2024-02-19 |
| Kanesa-thasan Niranjan | Other | 33 | $100.0K | $1.92M | 2024-02-19 |
| Cearley Cassia | Other | 30 | $0 | $620.0K | 2024-02-19 |
| Simpson Adam K. | Other | 63 | $0 | $3.67M | 2024-02-19 |
| Wassil Jim | Other | 7 | $0 | $0 | 2024-02-19 |
| Russo Thomas Joseph | Other | 18 | $0 | $302.2K | 2024-02-19 |
| Veneman Ann M | Other | 9 | $0 | $0 | 2024-02-19 |
| RA Capital Healthcare Fund LP | Director, 10% Owner | 7 | $836.5K | $0 | 2024-02-19 |
| MCDADE MARK | Other | 8 | $299.8K | $0 | 2024-02-19 |
| FIELDS HEIDI | Other | 9 | $0 | $0 | 2024-02-19 |
| Holtzman Douglas | Chief Scientific Officer | 24 | $0 | $607.6K | 2023-07-03 |
| Kolchinsky Peter | Director, 10% Owner | 3 | $0 | $0 | 2023-06-06 |
| Bekiroglu Elizabeth | General Counsel & Corp. Sec. | 5 | $0 | $72.1K | 2023-02-15 |
| Richardson Charles E | See Remarks | 10 | $0 | $15.0K | 2022-08-02 |
| NanoDimension III, L.P. | Other | 4 | $2.00M | $0 | 2021-08-02 |
| Qiming U.S. Healthcare Fund II, L.P. | Other | 6 | $3.32M | $0 | 2021-08-02 |
| Shah Rajeev M. | Director, 10% Owner | 6 | $40.00M | $0 | 2021-08-02 |
| Cormorant Global Healthcare Master Fund, LP | Other | 2 | $0 | $0 | 2021-08-02 |
| Gould Terry P | Director | 22 | $2.00M | $0 | 2021-08-02 |
| ADAMS STREET PARTNERS LLC | Other | 22 | $2.00M | $0 | 2021-08-02 |
| Sanofi | 10% Owner | 4 | $1.00M | $0 | 2021-08-02 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Kanesa-thasan Niranjan | Other | D To issuer deriv | 2024-02-19 | 2024-02-20 | 81,950 | — | $0 | 0 | SEC↗ |
| Kanesa-thasan Niranjan | Other | D To issuer deriv | 2024-02-19 | 2024-02-20 | 118,528 | — | $0 | 0 | SEC↗ |
| Kanesa-thasan Niranjan | Other | D To issuer deriv | 2024-02-19 | 2024-02-20 | 110,000 | — | $0 | 0 | SEC↗ |
| Kanesa-thasan Niranjan | Other | D To issuer deriv | 2024-02-19 | 2024-02-20 | 108,369 | — | $0 | 0 | SEC↗ |
| Kanesa-thasan Niranjan | Other | D To issuer deriv | 2024-02-19 | 2024-02-20 | 2,511 | — | $0 | 0 | SEC↗ |
| Kanesa-thasan Niranjan | Other | D To issuer deriv | 2024-02-19 | 2024-02-20 | 82,580 | — | $0 | 0 | SEC↗ |
| Kanesa-thasan Niranjan | Other | D To issuer deriv | 2024-02-19 | 2024-02-20 | 42,193 | — | $0 | 0 | SEC↗ |
| MCDADE MARK | Other | D To issuer deriv | 2024-02-19 | 2024-02-20 | 22,278 | — | $0 | 0 | SEC↗ |
| MCDADE MARK | Other | D To issuer deriv | 2024-02-19 | 2024-02-20 | 17,000 | — | $0 | 0 | SEC↗ |
| Shiver John W. | Other | D To issuer deriv | 2024-02-19 | 2024-02-20 | 17,000 | — | $0 | 0 | SEC↗ |
| Shiver John W. | Other | D To issuer deriv | 2024-02-19 | 2024-02-20 | 25,500 | — | $0 | 0 | SEC↗ |
| Shiver John W. | Other | D To issuer deriv | 2024-02-19 | 2024-02-20 | 9,643 | — | $0 | 0 | SEC↗ |
| Russo Thomas Joseph | Other | D To issuer deriv | 2024-02-19 | 2024-02-20 | 100,000 | — | $0 | 0 | SEC↗ |
| Russo Thomas Joseph | Other | D To issuer deriv | 2024-02-19 | 2024-02-20 | 97,500 | — | $0 | 0 | SEC↗ |
| Russo Thomas Joseph | Other | D To issuer deriv | 2024-02-19 | 2024-02-20 | 125,000 | — | $0 | 0 | SEC↗ |
| Russo Thomas Joseph | Other | D To issuer deriv | 2024-02-19 | 2024-02-20 | 376,590 | — | $0 | 0 | SEC↗ |
| Russo Thomas Joseph | Other | D To issuer deriv | 2024-02-19 | 2024-02-20 | 74,500 | — | $0 | 0 | SEC↗ |
| Wassil Jim | Other | D To issuer deriv | 2024-02-19 | 2024-02-20 | 17,000 | — | $0 | 0 | SEC↗ |
| Wassil Jim | Other | D To issuer deriv | 2024-02-19 | 2024-02-20 | 44,556 | — | $0 | 0 | SEC↗ |
| FIELDS HEIDI | Other | D To issuer deriv | 2024-02-19 | 2024-02-20 | 25,266 | — | $0 | 0 | SEC↗ |
| FIELDS HEIDI | Other | D To issuer deriv | 2024-02-19 | 2024-02-20 | 17,000 | — | $0 | 0 | SEC↗ |
| FIELDS HEIDI | Other | D To issuer deriv | 2024-02-19 | 2024-02-20 | 22,278 | — | $0 | 0 | SEC↗ |
| Cearley Cassia | Other | D To issuer deriv | 2024-02-19 | 2024-02-20 | 180,474 | — | $0 | 0 | SEC↗ |
| Cearley Cassia | Other | D To issuer deriv | 2024-02-19 | 2024-02-20 | 83,250 | — | $0 | 0 | SEC↗ |
| Cearley Cassia | Other | D To issuer deriv | 2024-02-19 | 2024-02-20 | 89,400 | — | $0 | 0 | SEC↗ |
| Cearley Cassia | Other | D To issuer deriv | 2024-02-19 | 2024-02-20 | 2,511 | — | $0 | 0 | SEC↗ |
| Cearley Cassia | Other | D To issuer deriv | 2024-02-19 | 2024-02-20 | 100,000 | — | $0 | 0 | SEC↗ |
| Cearley Cassia | Other | D To issuer deriv | 2024-02-19 | 2024-02-20 | 104,204 | — | $0 | 0 | SEC↗ |
| Cearley Cassia | Other | D To issuer deriv | 2024-02-19 | 2024-02-20 | 140,000 | — | $0 | 0 | SEC↗ |
| Veneman Ann M | Other | D To issuer deriv | 2024-02-19 | 2024-02-20 | 25,500 | — | $0 | 0 | SEC↗ |
| Veneman Ann M | Other | D To issuer deriv | 2024-02-19 | 2024-02-20 | 17,000 | — | $0 | 0 | SEC↗ |
| Veneman Ann M | Other | D To issuer deriv | 2024-02-19 | 2024-02-20 | 22,278 | — | $0 | 0 | SEC↗ |
| Khan Amin | Other | D To issuer deriv | 2024-02-19 | 2024-02-20 | 120,000 | — | $0 | 0 | SEC↗ |
| Khan Amin | Other | D To issuer deriv | 2024-02-19 | 2024-02-20 | 180,000 | — | $0 | 0 | SEC↗ |
| Simpson Adam K. | Other | D To issuer deriv | 2024-02-19 | 2024-02-20 | 1,347,546 | — | $0 | 0 | SEC↗ |
| Simpson Adam K. | Other | D To issuer deriv | 2024-02-19 | 2024-02-20 | 375,000 | — | $0 | 0 | SEC↗ |
| Simpson Adam K. | Other | D To issuer deriv | 2024-02-19 | 2024-02-20 | 350,000 | — | $0 | 0 | SEC↗ |
| Simpson Adam K. | Other | D To issuer deriv | 2024-02-19 | 2024-02-20 | 317,866 | — | $0 | 0 | SEC↗ |
| Simpson Adam K. | Other | D To issuer deriv | 2024-02-19 | 2024-02-20 | 237,146 | — | $0 | 0 | SEC↗ |
| Simpson Adam K. | Other | D To issuer deriv | 2024-02-19 | 2024-02-20 | 191,449 | — | $0 | 0 | SEC↗ |
| RA Capital Healthcare Fund LP | Director, 10% Owner | D To issuer deriv | 2024-02-19 | 2024-02-20 | 22,278 | — | $0 | 0 | SEC↗ |
| RA Capital Healthcare Fund LP | Director, 10% Owner | D To issuer deriv | 2024-02-19 | 2024-02-20 | 17,000 | — | $0 | 0 | SEC↗ |
| Kanesa-thasan Niranjan | Other | U Tender | 2024-02-19 | 2024-02-20 | 223,980 | — | $0 | 0 | SEC↗ |
| MCDADE MARK | Other | U Tender | 2024-02-19 | 2024-02-20 | 3,510,228 | — | $0 | 0 | SEC↗ |
| MCDADE MARK | Other | U Tender | 2024-02-19 | 2024-02-20 | 55,786 | — | $0 | 0 | SEC↗ |
| Shiver John W. | Other | D To issuer | 2024-02-19 | 2024-02-20 | 2,833 | — | $0 | 0 | SEC↗ |
| Shiver John W. | Other | U Tender | 2024-02-19 | 2024-02-20 | 8,066 | — | $0 | 0 | SEC↗ |
| Russo Thomas Joseph | Other | U Tender | 2024-02-19 | 2024-02-20 | 39,367 | — | $0 | 0 | SEC↗ |
| Wassil Jim | Other | D To issuer | 2024-02-19 | 2024-02-20 | 7,392 | — | $0 | 0 | SEC↗ |
| Wassil Jim | Other | U Tender | 2024-02-19 | 2024-02-20 | 3,695 | — | $0 | 0 | SEC↗ |
| FIELDS HEIDI | Other | U Tender | 2024-02-19 | 2024-02-20 | 11,376 | — | $0 | 0 | SEC↗ |
| FIELDS HEIDI | Other | D To issuer | 2024-02-19 | 2024-02-20 | 2,917 | — | $0 | 0 | SEC↗ |
| Cearley Cassia | Other | U Tender | 2024-02-19 | 2024-02-20 | 131,799 | — | $0 | 0 | SEC↗ |
| Veneman Ann M | Other | U Tender | 2024-02-19 | 2024-02-20 | 11,209 | — | $0 | 0 | SEC↗ |
| Veneman Ann M | Other | D To issuer | 2024-02-19 | 2024-02-20 | 2,834 | — | $0 | 0 | SEC↗ |
| Simpson Adam K. | Other | U Tender | 2024-02-19 | 2024-02-20 | 129,032 | — | $0 | 0 | SEC↗ |
| Simpson Adam K. | Other | U Tender | 2024-02-19 | 2024-02-20 | 129,032 | — | $0 | 0 | SEC↗ |
| Simpson Adam K. | Other | U Tender | 2024-02-19 | 2024-02-20 | 525,044 | — | $0 | 0 | SEC↗ |
| Simpson Adam K. | Other | U Tender | 2024-02-19 | 2024-02-20 | 358,657 | — | $0 | 0 | SEC↗ |
| RA Capital Healthcare Fund LP | Director, 10% Owner | U Tender | 2024-02-19 | 2024-02-20 | 5,543 | — | $0 | 0 | SEC↗ |
| RA Capital Healthcare Fund LP | Director, 10% Owner | U Tender | 2024-02-19 | 2024-02-20 | 5,324,897 | — | $0 | 0 | SEC↗ |
| RA Capital Healthcare Fund LP | Director, 10% Owner | U Tender | 2024-02-19 | 2024-02-20 | 638,668 | — | $0 | 0 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | M Exercise deriv | 2024-02-01 | 2024-02-02 | 15,000 | — | $0 | 191,449 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | M Exercise | 2024-02-01 | 2024-02-02 | 15,000 | $1.04 | $15.6K | 373,657 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | G Gift | 2024-02-01 | 2024-02-02 | 6,532 | — | $0 | 525,044 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | S Sale | 2024-02-01 | 2024-02-02 | 15,000 | $15.29 | $229.3K | 358,657 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | M Exercise deriv | 2024-01-22 | 2024-01-23 | 4,789 | — | $0 | 0 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | M Exercise deriv | 2024-01-22 | 2024-01-23 | 93,227 | — | $0 | 206,449 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | M Exercise | 2024-01-22 | 2024-01-23 | 93,227 | $1.04 | $97.0K | 358,657 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | M Exercise | 2024-01-22 | 2024-01-23 | 4,789 | $0.84 | $4.0K | 265,430 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | M Exercise deriv | 2024-01-02 | 2024-01-04 | 15,000 | — | $0 | 299,676 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | M Exercise | 2024-01-02 | 2024-01-04 | 15,000 | $1.04 | $15.6K | 275,641 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | S Sale | 2024-01-02 | 2024-01-04 | 15,000 | $15.67 | $235.1K | 260,641 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | M Exercise deriv | 2023-12-21 | 2023-12-22 | 102,574 | — | $0 | 314,676 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | M Exercise deriv | 2023-12-21 | 2023-12-22 | 40,000 | — | $0 | 237,146 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | M Exercise deriv | 2023-12-21 | 2023-12-22 | 23,343 | — | $0 | 4,789 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | M Exercise | 2023-12-21 | 2023-12-22 | 102,574 | $1.04 | $106.7K | 287,298 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | M Exercise | 2023-12-21 | 2023-12-22 | 40,000 | $2.47 | $98.8K | 327,298 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | M Exercise | 2023-12-21 | 2023-12-22 | 23,343 | $0.84 | $19.6K | 350,641 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | S Sale | 2023-12-21 | 2023-12-22 | 40,000 | $15.43 | $617.2K | 260,641 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | S Sale | 2023-12-21 | 2023-12-22 | 50,000 | $15.44 | $772.0K | 300,641 | SEC↗ |
| Cearley Cassia | Chief Business Officer | S Sale | 2023-12-20 | 2023-12-22 | 7,934 | $15.46 | $122.7K | 130,694 | SEC↗ |
| Kanesa-thasan Niranjan | Chief Medical Officer | S Sale | 2023-12-20 | 2023-12-22 | 11,884 | $15.46 | $183.7K | 223,980 | SEC↗ |
| Russo Thomas Joseph | Chief Financial Officer | S Sale | 2023-12-20 | 2023-12-22 | 10,753 | $15.46 | $166.2K | 42,467 | SEC↗ |
| Russo Thomas Joseph | Chief Financial Officer | S Sale | 2023-12-20 | 2023-12-22 | 4,430 | $15.47 | $68.5K | 38,037 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | S Sale | 2023-12-20 | 2023-12-22 | 62,205 | $15.46 | $961.7K | 184,724 | SEC↗ |
| Cearley Cassia | Chief Business Officer | S Sale | 2023-12-13 | 2023-12-15 | 8,759 | $16.01 | $140.2K | 131,200 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | M Exercise deriv | 2023-08-01 | 2023-08-01 | 3,000 | — | $0 | 28,132 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | M Exercise | 2023-08-01 | 2023-08-01 | 3,000 | $0.84 | $2.5K | 246,930 | SEC↗ |
| Cearley Cassia | Chief Business Officer | S Sale | 2023-07-31 | 2023-08-01 | 1,888 | $8.86 | $16.7K | 139,959 | SEC↗ |
| Russo Thomas Joseph | Chief Financial Officer | S Sale | 2023-07-31 | 2023-08-01 | 3,066 | $8.86 | $27.2K | 45,620 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | S Sale | 2023-07-31 | 2023-08-01 | 11,788 | $8.86 | $104.4K | 243,930 | SEC↗ |
| Kanesa-thasan Niranjan | Chief Medical Officer | S Sale | 2023-07-31 | 2023-08-01 | 3,323 | $8.86 | $29.4K | 235,864 | SEC↗ |
| Holtzman Douglas | Chief Scientific Officer | M Exercise deriv | 2023-07-03 | 2023-07-03 | 16,356 | — | $0 | 28,621 | SEC↗ |
| Holtzman Douglas | Chief Scientific Officer | M Exercise | 2023-07-03 | 2023-07-03 | 16,356 | $1.04 | $17.0K | 306,410 | SEC↗ |
| Holtzman Douglas | Chief Scientific Officer | S Sale | 2023-07-03 | 2023-07-03 | 14,261 | $8.74 | $124.6K | 292,149 | SEC↗ |
| Holtzman Douglas | Chief Scientific Officer | S Sale | 2023-07-03 | 2023-07-03 | 2,095 | $9.59 | $20.1K | 290,054 | SEC↗ |
| Khan Amin | EVP, Head of Research & Dev. | A Award deriv | 2023-06-12 | 2023-06-14 | 180,000 | — | $0 | 180,000 | SEC↗ |
| FIELDS HEIDI | Director | A Award deriv | 2023-06-06 | 2023-06-08 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Shiver John W. | Director | A Award deriv | 2023-06-06 | 2023-06-08 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Veneman Ann M | Director | A Award deriv | 2023-06-06 | 2023-06-08 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Wassil Jim | Director | A Award deriv | 2023-06-06 | 2023-06-08 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | A Award deriv | 2023-06-06 | 2023-06-08 | 17,000 | — | $0 | 17,000 | SEC↗ |
| MCDADE MARK | Director | A Award deriv | 2023-06-06 | 2023-06-08 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Cearley Cassia | Chief Business Officer | S Sale | 2023-05-23 | 2023-05-25 | 10,000 | $10.00 | $100.0K | 141,847 | SEC↗ |
| Holtzman Douglas | Chief Scientific Officer | M Exercise deriv | 2023-04-03 | 2023-04-05 | 20,443 | — | $0 | 44,977 | SEC↗ |
| Holtzman Douglas | Chief Scientific Officer | S Sale | 2023-04-03 | 2023-04-05 | 20,143 | $6.08 | $122.5K | 290,354 | SEC↗ |
| Holtzman Douglas | Chief Scientific Officer | M Exercise | 2023-04-03 | 2023-04-05 | 20,443 | $1.04 | $21.3K | 310,497 | SEC↗ |
| Holtzman Douglas | Chief Scientific Officer | S Sale | 2023-04-03 | 2023-04-05 | 300 | $6.56 | $2.0K | 290,054 | SEC↗ |
| Cearley Cassia | Chief Business Officer | S Sale | 2023-03-06 | 2023-03-08 | 5,000 | $7.75 | $38.8K | 151,847 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | M Exercise deriv | 2023-02-15 | 2023-02-16 | 10,677 | — | $0 | 417,250 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | A Award deriv | 2023-02-15 | 2023-02-17 | 350,000 | — | $0 | 350,000 | SEC↗ |
| Cearley Cassia | Chief Business Officer | A Award deriv | 2023-02-15 | 2023-02-17 | 140,000 | — | $0 | 140,000 | SEC↗ |
| Holtzman Douglas | Chief Scientific Officer | A Award deriv | 2023-02-15 | 2023-02-17 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Kanesa-thasan Niranjan | Chief Medical Officer | A Award deriv | 2023-02-15 | 2023-02-17 | 110,000 | — | $0 | 110,000 | SEC↗ |
| Bekiroglu Elizabeth | General Counsel & Corp. Sec. | A Award deriv | 2023-02-15 | 2023-02-17 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Russo Thomas Joseph | Chief Financial Officer | A Award deriv | 2023-02-15 | 2023-02-17 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | M Exercise | 2023-02-15 | 2023-02-16 | 10,677 | $1.04 | $11.1K | 255,718 | SEC↗ |
| Holtzman Douglas | Chief Scientific Officer | S Sale | 2023-02-14 | 2023-02-15 | 3,349 | $10.17 | $34.1K | 290,054 | SEC↗ |
| Cearley Cassia | Chief Business Officer | S Sale | 2023-02-13 | 2023-02-15 | 1,660 | $10.69 | $17.7K | 156,847 | SEC↗ |
| Kanesa-thasan Niranjan | Chief Medical Officer | S Sale | 2023-02-13 | 2023-02-15 | 1,794 | $10.69 | $19.2K | 239,187 | SEC↗ |
| Russo Thomas Joseph | Chief Financial Officer | S Sale | 2023-02-13 | 2023-02-15 | 1,902 | $10.69 | $20.3K | 48,686 | SEC↗ |
| Holtzman Douglas | Chief Scientific Officer | S Sale | 2023-02-13 | 2023-02-15 | 1,522 | $10.69 | $16.3K | 293,403 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | S Sale | 2023-02-13 | 2023-02-15 | 7,506 | $10.69 | $80.2K | 245,041 | SEC↗ |
| Bekiroglu Elizabeth | General Counsel & Corp. Sec. | S Sale | 2023-02-13 | 2023-02-15 | 5,922 | $10.69 | $63.3K | 103,007 | SEC↗ |
| Cearley Cassia | Chief Business Officer | M Exercise deriv | 2023-01-30 | 2023-01-31 | 25,102 | — | $0 | 2,511 | SEC↗ |
| Cearley Cassia | Chief Business Officer | M Exercise | 2023-01-30 | 2023-01-31 | 25,102 | $0.84 | $21.1K | 156,840 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | M Exercise deriv | 2023-01-25 | 2023-01-27 | 2,395 | — | $0 | 31,132 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | M Exercise deriv | 2023-01-25 | 2023-01-27 | 10,678 | — | $0 | 427,927 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | M Exercise | 2023-01-25 | 2023-01-27 | 2,395 | $0.84 | $2.0K | 241,869 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | M Exercise | 2023-01-25 | 2023-01-27 | 10,678 | $1.04 | $11.1K | 252,547 | SEC↗ |
| Kanesa-thasan Niranjan | Chief Medical Officer | M Exercise deriv | 2023-01-04 | 2024-01-05 | 74,648 | — | $0 | 42,193 | SEC↗ |
| Kanesa-thasan Niranjan | Chief Medical Officer | M Exercise deriv | 2023-01-04 | 2024-01-05 | 11,947 | — | $0 | 108,369 | SEC↗ |
| Kanesa-thasan Niranjan | Chief Medical Officer | M Exercise deriv | 2023-01-04 | 2024-01-05 | 5,972 | — | $0 | 118,528 | SEC↗ |
| Kanesa-thasan Niranjan | Chief Medical Officer | M Exercise deriv | 2023-01-04 | 2024-01-05 | 13,806 | — | $0 | 2,511 | SEC↗ |
| Kanesa-thasan Niranjan | Chief Medical Officer | M Exercise | 2023-01-04 | 2024-01-05 | 13,806 | $0.84 | $11.6K | 237,786 | SEC↗ |
| Kanesa-thasan Niranjan | Chief Medical Officer | S Sale | 2023-01-04 | 2024-01-05 | 106,373 | $15.70 | $1.67M | 223,980 | SEC↗ |
| Kanesa-thasan Niranjan | Chief Medical Officer | M Exercise | 2023-01-04 | 2024-01-05 | 5,972 | $15.00 | $89.6K | 330,353 | SEC↗ |
| Kanesa-thasan Niranjan | Chief Medical Officer | M Exercise | 2023-01-04 | 2024-01-05 | 11,947 | $5.90 | $70.5K | 324,381 | SEC↗ |
| Kanesa-thasan Niranjan | Chief Medical Officer | M Exercise | 2023-01-04 | 2024-01-05 | 74,648 | $1.04 | $77.6K | 312,434 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | M Exercise deriv | 2022-12-23 | 2022-12-23 | 14,369 | — | $0 | 33,527 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | M Exercise | 2022-12-23 | 2022-12-23 | 14,369 | $0.84 | $12.1K | 239,474 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | S Sale | 2022-12-21 | 2022-12-23 | 66,764 | $8.96 | $598.2K | 225,105 | SEC↗ |
| Holtzman Douglas | Chief Scientific Officer | S Sale | 2022-12-15 | 2022-12-16 | 19,648 | $11.14 | $218.9K | 2,792 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | A Award deriv | 2022-11-10 | 2022-11-14 | 277,146 | — | $0 | 277,146 | SEC↗ |
| Kanesa-thasan Niranjan | Chief Medical Officer | A Award deriv | 2022-11-10 | 2022-11-14 | 82,580 | — | $0 | 82,580 | SEC↗ |
| Cearley Cassia | Chief Business Officer | A Award deriv | 2022-11-10 | 2022-11-14 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Holtzman Douglas | Chief Scientific Officer | A Award deriv | 2022-11-10 | 2022-11-14 | 82,580 | — | $0 | 82,580 | SEC↗ |
| Russo Thomas Joseph | Chief Financial Officer | A Award deriv | 2022-11-10 | 2022-11-14 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Bekiroglu Elizabeth | General Counsel & Corp. Sec. | A Award deriv | 2022-11-10 | 2022-11-14 | 88,900 | — | $0 | 88,900 | SEC↗ |
| Bekiroglu Elizabeth | General Counsel & Corp. Sec. | S Sale | 2022-09-08 | 2022-09-09 | 1,813 | $4.87 | $8.8K | 108,929 | SEC↗ |
| Cearley Cassia | Chief Business Officer | S Sale | 2022-08-02 | 2022-08-02 | 303 | $6.70 | $2.0K | 131,738 | SEC↗ |
| Kanesa-thasan Niranjan | Chief Medical Officer | S Sale | 2022-08-02 | 2022-08-02 | 543 | $6.70 | $3.6K | 239,314 | SEC↗ |
| Richardson Charles E | SVP, Technical Operations | S Sale | 2022-08-02 | 2022-08-02 | 371 | $6.70 | $2.5K | 165,168 | SEC↗ |
| Holtzman Douglas | Chief Scientific Officer | S Sale | 2022-08-02 | 2022-08-02 | 453 | $6.70 | $3.0K | 293,258 | SEC↗ |
| Russo Thomas Joseph | Chief Financial Officer | S Sale | 2022-08-02 | 2022-08-02 | 495 | $6.70 | $3.3K | 48,921 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | S Sale | 2022-08-02 | 2022-08-02 | 1,904 | $6.70 | $12.8K | 291,869 | SEC↗ |
| Cearley Cassia | Chief Business Officer | S Sale | 2022-08-01 | 2022-08-02 | 1,118 | $6.64 | $7.4K | 132,041 | SEC↗ |
| Kanesa-thasan Niranjan | Chief Medical Officer | S Sale | 2022-08-01 | 2022-08-02 | 2,001 | $6.64 | $13.3K | 239,857 | SEC↗ |
| Richardson Charles E | SVP, Technical Operations | S Sale | 2022-08-01 | 2022-08-02 | 1,368 | $6.64 | $9.1K | 165,539 | SEC↗ |
| Holtzman Douglas | Chief Scientific Officer | S Sale | 2022-08-01 | 2022-08-02 | 9,337 | $6.64 | $62.0K | 293,711 | SEC↗ |
| Russo Thomas Joseph | Chief Financial Officer | S Sale | 2022-08-01 | 2022-08-02 | 1,825 | $6.64 | $12.1K | 49,416 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | S Sale | 2022-08-01 | 2022-08-02 | 7,017 | $6.64 | $46.6K | 293,772 | SEC↗ |
| Cearley Cassia | Chief Business Officer | S Sale | 2022-07-29 | 2022-08-02 | 391 | $7.11 | $2.8K | 133,159 | SEC↗ |
| Kanesa-thasan Niranjan | Chief Medical Officer | S Sale | 2022-07-29 | 2022-08-02 | 701 | $7.11 | $5.0K | 241,858 | SEC↗ |
| Richardson Charles E | SVP, Technical Operations | S Sale | 2022-07-29 | 2022-08-02 | 479 | $7.11 | $3.4K | 166,907 | SEC↗ |
| Holtzman Douglas | Chief Scientific Officer | S Sale | 2022-07-29 | 2022-08-02 | 585 | $7.11 | $4.2K | 303,048 | SEC↗ |
| Russo Thomas Joseph | Chief Financial Officer | S Sale | 2022-07-29 | 2022-08-02 | 639 | $7.11 | $4.5K | 51,241 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | S Sale | 2022-07-29 | 2022-08-02 | 2,456 | $7.11 | $17.5K | 300,789 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | M Exercise deriv | 2022-07-01 | 2022-07-06 | 7,185 | — | $0 | 47,896 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | M Exercise | 2022-07-01 | 2022-07-06 | 7,185 | $0.84 | $6.0K | 303,245 | SEC↗ |
| MCDADE MARK | Director | A Award deriv | 2022-06-10 | 2022-06-14 | 22,278 | — | $0 | 22,278 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | A Award deriv | 2022-06-10 | 2022-06-14 | 22,278 | — | $0 | 22,278 | SEC↗ |
| FIELDS HEIDI | Director | A Award deriv | 2022-06-10 | 2022-06-14 | 22,278 | — | $0 | 22,278 | SEC↗ |
| Shiver John W. | Director | A Award deriv | 2022-06-10 | 2022-06-14 | 9,643 | — | $0 | 9,643 | SEC↗ |
| Veneman Ann M | Director | A Award deriv | 2022-06-10 | 2022-06-14 | 22,278 | — | $0 | 22,278 | SEC↗ |
| Wassil Jim | Director | A Award deriv | 2022-06-10 | 2022-06-14 | 44,556 | — | $0 | 44,556 | SEC↗ |
| MCDADE MARK | Director | A Award | 2022-06-10 | 2022-06-14 | 5,543 | — | $0 | 55,786 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | A Award | 2022-06-10 | 2022-06-14 | 5,543 | — | $0 | 5,543 | SEC↗ |
| FIELDS HEIDI | Director | A Award | 2022-06-10 | 2022-06-14 | 5,543 | — | $0 | 14,293 | SEC↗ |
| Shiver John W. | Director | A Award | 2022-06-10 | 2022-06-14 | 2,399 | — | $0 | 10,899 | SEC↗ |
| Veneman Ann M | Director | A Award | 2022-06-10 | 2022-06-14 | 5,543 | — | $0 | 14,043 | SEC↗ |
| Wassil Jim | Director | A Award | 2022-06-10 | 2022-06-14 | 11,087 | — | $0 | 11,087 | SEC↗ |
| MCDADE MARK | Director | P Buy | 2022-04-01 | 2022-04-05 | 42,225 | $7.10 | $299.8K | 50,243 | SEC↗ |
| RA Capital Healthcare Fund LP | Director, 10% Owner | P Buy | 2022-03-29 | 2022-03-30 | 8,900 | $4.75 | $42.3K | 5,963,565 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | M Exercise deriv | 2022-03-28 | 2022-03-30 | 4,789 | — | $0 | 55,081 | SEC↗ |
| RA Capital Healthcare Fund LP | Director, 10% Owner | P Buy | 2022-03-28 | 2022-03-30 | 175,318 | $4.53 | $794.2K | 5,953,665 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | M Exercise | 2022-03-28 | 2022-03-30 | 4,789 | $0.84 | $4.0K | 220,482 | SEC↗ |
| Cearley Cassia | Chief Business Officer | M Exercise deriv | 2022-03-18 | 2022-03-22 | 35,137 | — | $0 | 27,613 | SEC↗ |
| Cearley Cassia | Chief Business Officer | M Exercise | 2022-03-18 | 2022-03-22 | 35,137 | $0.84 | $29.5K | 133,550 | SEC↗ |
| Cearley Cassia | Chief Business Officer | S Sale | 2022-03-07 | 2022-03-09 | 9,516 | $17.13 | $163.0K | 98,897 | SEC↗ |
| Cearley Cassia | Chief Business Officer | S Sale | 2022-03-07 | 2022-03-09 | 484 | $17.81 | $8.6K | 98,413 | SEC↗ |
| Holtzman Douglas | Chief Scientific Officer | G Gift | 2022-02-18 | 2022-08-02 | 20,000 | — | $0 | 22,440 | SEC↗ |
| Richardson Charles E | SVP, Technical Operations | M Exercise deriv | 2022-02-14 | 2022-02-16 | 66,375 | — | $0 | 43,489 | SEC↗ |
| Richardson Charles E | SVP, Technical Operations | M Exercise deriv | 2022-02-14 | 2022-02-16 | 6,186 | — | $0 | 16,657 | SEC↗ |
| Richardson Charles E | SVP, Technical Operations | M Exercise | 2022-02-14 | 2022-02-16 | 6,186 | $1.04 | $6.4K | 167,386 | SEC↗ |
| Richardson Charles E | SVP, Technical Operations | M Exercise | 2022-02-14 | 2022-02-16 | 66,375 | $0.84 | $55.8K | 161,200 | SEC↗ |
| Cearley Cassia | Chief Business Officer | A Award deriv | 2022-02-10 | 2022-02-14 | 89,400 | — | $0 | 89,400 | SEC↗ |
| Holtzman Douglas | Chief Scientific Officer | A Award deriv | 2022-02-10 | 2022-02-14 | 81,950 | — | $0 | 81,950 | SEC↗ |
| Kanesa-thasan Niranjan | Chief Medical Officer | A Award deriv | 2022-02-10 | 2022-02-14 | 81,950 | — | $0 | 81,950 | SEC↗ |
| Richardson Charles E | SVP, Technical Operations | A Award deriv | 2022-02-10 | 2022-02-14 | 67,050 | — | $0 | 67,050 | SEC↗ |
| Russo Thomas Joseph | Chief Financial Officer | A Award deriv | 2022-02-10 | 2022-02-14 | 74,500 | — | $0 | 74,500 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | A Award deriv | 2022-02-10 | 2022-02-14 | 317,866 | — | $0 | 317,866 | SEC↗ |
| Bekiroglu Elizabeth | General Counsel & Corp. Sec. | A Award | 2022-02-10 | 2022-02-14 | 82,992 | — | $0 | 110,742 | SEC↗ |
| Cearley Cassia | Chief Business Officer | A Award | 2022-02-10 | 2022-02-14 | 21,256 | — | $0 | 108,413 | SEC↗ |
| Holtzman Douglas | Chief Scientific Officer | A Award | 2022-02-10 | 2022-02-14 | 19,485 | — | $0 | 303,633 | SEC↗ |
| Kanesa-thasan Niranjan | Chief Medical Officer | A Award | 2022-02-10 | 2022-02-14 | 19,485 | — | $0 | 242,559 | SEC↗ |
| Richardson Charles E | SVP, Technical Operations | A Award | 2022-02-10 | 2022-02-14 | 15,942 | — | $0 | 94,825 | SEC↗ |
| Russo Thomas Joseph | Chief Financial Officer | A Award | 2022-02-10 | 2022-02-14 | 17,714 | — | $0 | 51,880 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | A Award | 2022-02-10 | 2022-02-14 | 75,578 | — | $0 | 291,271 | SEC↗ |
| Kanesa-thasan Niranjan | Chief Medical Officer | M Exercise deriv | 2022-02-02 | 2022-02-04 | 38,947 | — | $0 | 116,841 | SEC↗ |
| Kanesa-thasan Niranjan | Chief Medical Officer | M Exercise deriv | 2022-02-02 | 2022-02-04 | 13,805 | — | $0 | 16,317 | SEC↗ |
| Kanesa-thasan Niranjan | Chief Medical Officer | M Exercise | 2022-02-02 | 2022-02-04 | 38,947 | $1.04 | $40.5K | 221,408 | SEC↗ |
| Kanesa-thasan Niranjan | Chief Medical Officer | M Exercise | 2022-02-02 | 2022-02-04 | 13,805 | $0.84 | $11.6K | 182,461 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | M Exercise deriv | 2022-01-26 | 2022-01-28 | 73,929 | — | $0 | 438,605 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | M Exercise deriv | 2022-01-26 | 2022-01-28 | 16,764 | — | $0 | 59,870 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | M Exercise | 2022-01-26 | 2022-01-28 | 16,764 | $0.84 | $14.1K | 141,764 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | M Exercise | 2022-01-26 | 2022-01-28 | 73,929 | $1.04 | $76.9K | 215,693 | SEC↗ |
| Shiver John W. | Director | A Award deriv | 2022-01-03 | 2022-01-05 | 25,500 | — | $0 | 25,500 | SEC↗ |
| Shiver John W. | Director | A Award | 2022-01-03 | 2022-01-05 | 8,500 | — | $0 | 8,500 | SEC↗ |
| Holtzman Douglas | Chief Scientific Officer | G Gift | 2021-12-31 | 2022-02-14 | 10,000 | — | $0 | 42,440 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | G Gift | 2021-12-21 | 2022-01-28 | 125,000 | — | $0 | 129,032 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | G Gift | 2021-12-21 | 2022-01-28 | 125,000 | — | $0 | 531,576 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | G Gift | 2021-12-21 | 2022-01-28 | 125,000 | — | $0 | 656,576 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | G Gift | 2021-12-21 | 2022-01-28 | 125,000 | — | $0 | 129,032 | SEC↗ |
| Cearley Cassia | Chief Business Officer | M Exercise deriv | 2021-11-15 | 2021-11-17 | 22,598 | — | $0 | 62,750 | SEC↗ |
| Cearley Cassia | Chief Business Officer | M Exercise | 2021-11-15 | 2021-11-17 | 22,598 | $0.83 | $18.8K | 85,491 | SEC↗ |
| Sanofi | 10% Owner | C Conversion deriv | 2021-08-02 | 2021-08-02 | 12,480,498 | — | $0 | 0 | SEC↗ |
| Sanofi | 10% Owner | C Conversion deriv | 2021-08-02 | 2021-08-02 | 354,393 | — | $0 | 0 | SEC↗ |
| Holtzman Douglas | Chief Scientific Officer | C Conversion deriv | 2021-08-02 | 2021-08-02 | 206,323 | — | $0 | 0 | SEC↗ |
| Holtzman Douglas | Chief Scientific Officer | C Conversion deriv | 2021-08-02 | 2021-08-02 | 11,602 | — | $0 | 0 | SEC↗ |
| Qiming U.S. Healthcare Fund II | Other | C Conversion deriv | 2021-08-02 | 2021-08-02 | 12,480,498 | — | $0 | 0 | SEC↗ |
| Qiming U.S. Healthcare Fund II | Other | C Conversion deriv | 2021-08-02 | 2021-08-02 | 1,275,817 | — | $0 | 0 | SEC↗ |
| ADAMS STREET PARTNERS LLC | Other | C Conversion deriv | 2021-08-02 | 2021-08-03 | 1,348,119 | — | $0 | 0 | SEC↗ |
| ADAMS STREET PARTNERS LLC | Other | C Conversion deriv | 2021-08-02 | 2021-08-03 | 1,042,120 | — | $0 | 0 | SEC↗ |
| ADAMS STREET PARTNERS LLC | Other | C Conversion deriv | 2021-08-02 | 2021-08-03 | 3,509,939 | — | $0 | 0 | SEC↗ |
| ADAMS STREET PARTNERS LLC | Other | C Conversion deriv | 2021-08-02 | 2021-08-03 | 3,631,066 | — | $0 | 0 | SEC↗ |
| ADAMS STREET PARTNERS LLC | Other | C Conversion deriv | 2021-08-02 | 2021-08-03 | 79,734 | — | $0 | 0 | SEC↗ |
| ADAMS STREET PARTNERS LLC | Other | C Conversion deriv | 2021-08-02 | 2021-08-03 | 171,505 | — | $0 | 0 | SEC↗ |
| ADAMS STREET PARTNERS LLC | Other | C Conversion deriv | 2021-08-02 | 2021-08-03 | 114,843 | — | $0 | 0 | SEC↗ |
| ADAMS STREET PARTNERS LLC | Other | C Conversion deriv | 2021-08-02 | 2021-08-03 | 88,775 | — | $0 | 0 | SEC↗ |
| ADAMS STREET PARTNERS LLC | Other | C Conversion deriv | 2021-08-02 | 2021-08-03 | 299,003 | — | $0 | 0 | SEC↗ |
| ADAMS STREET PARTNERS LLC | Other | C Conversion deriv | 2021-08-02 | 2021-08-03 | 309,321 | — | $0 | 0 | SEC↗ |
| ADAMS STREET PARTNERS LLC | Other | C Conversion deriv | 2021-08-02 | 2021-08-03 | 935,985 | — | $0 | 0 | SEC↗ |
| ADAMS STREET PARTNERS LLC | Other | C Conversion deriv | 2021-08-02 | 2021-08-03 | 2,013,269 | — | $0 | 0 | SEC↗ |
| Gould Terry P | Director | C Conversion deriv | 2021-08-02 | 2021-08-03 | 3,631,066 | — | $0 | 0 | SEC↗ |
| Gould Terry P | Director | C Conversion deriv | 2021-08-02 | 2021-08-03 | 79,734 | — | $0 | 0 | SEC↗ |
| Gould Terry P | Director | C Conversion deriv | 2021-08-02 | 2021-08-03 | 171,505 | — | $0 | 0 | SEC↗ |
| Gould Terry P | Director | C Conversion deriv | 2021-08-02 | 2021-08-03 | 3,509,939 | — | $0 | 0 | SEC↗ |
| Gould Terry P | Director | C Conversion deriv | 2021-08-02 | 2021-08-03 | 1,042,120 | — | $0 | 0 | SEC↗ |
| Gould Terry P | Director | C Conversion deriv | 2021-08-02 | 2021-08-03 | 1,348,119 | — | $0 | 0 | SEC↗ |
| Gould Terry P | Director | C Conversion deriv | 2021-08-02 | 2021-08-03 | 2,013,269 | — | $0 | 0 | SEC↗ |
| Gould Terry P | Director | C Conversion deriv | 2021-08-02 | 2021-08-03 | 935,985 | — | $0 | 0 | SEC↗ |
| Gould Terry P | Director | C Conversion deriv | 2021-08-02 | 2021-08-03 | 309,321 | — | $0 | 0 | SEC↗ |
| Gould Terry P | Director | C Conversion deriv | 2021-08-02 | 2021-08-03 | 299,003 | — | $0 | 0 | SEC↗ |
| Gould Terry P | Director | C Conversion deriv | 2021-08-02 | 2021-08-03 | 88,775 | — | $0 | 0 | SEC↗ |
| Gould Terry P | Director | C Conversion deriv | 2021-08-02 | 2021-08-03 | 114,843 | — | $0 | 0 | SEC↗ |
| Cormorant Global Healthcare Ma | Other | C Conversion deriv | 2021-08-02 | 2021-08-04 | 426,393 | — | $0 | 0 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | C Conversion deriv | 2021-08-02 | 2021-08-04 | 10,995,066 | — | $0 | 0 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | C Conversion deriv | 2021-08-02 | 2021-08-04 | 1,940,306 | — | $0 | 0 | SEC↗ |
| NanoDimension III, L.P. | Other | C Conversion deriv | 2021-08-02 | 2021-08-04 | 10,400,415 | — | $0 | 0 | SEC↗ |
| NanoDimension III, L.P. | Other | C Conversion deriv | 2021-08-02 | 2021-08-04 | 1,027,741 | — | $0 | 0 | SEC↗ |
| Sanofi | 10% Owner | C Conversion | 2021-08-02 | 2021-08-02 | 3,088,502 | — | $0 | 3,088,502 | SEC↗ |
| Sanofi | 10% Owner | P Buy | 2021-08-02 | 2021-08-02 | 66,667 | $15.00 | $1.00M | 3,155,169 | SEC↗ |
| Kanesa-thasan Niranjan | Chief Medical Officer | P Buy | 2021-08-02 | 2021-08-02 | 6,666 | $15.00 | $100.0K | 6,666 | SEC↗ |
| Holtzman Douglas | Chief Scientific Officer | C Conversion | 2021-08-02 | 2021-08-02 | 52,440 | — | $0 | 52,440 | SEC↗ |
| Qiming U.S. Healthcare Fund II | Other | P Buy | 2021-08-02 | 2021-08-02 | 8,018 | $15.00 | $120.3K | 3,518,246 | SEC↗ |
| Qiming U.S. Healthcare Fund II | Other | C Conversion | 2021-08-02 | 2021-08-02 | 3,310,228 | — | $0 | 3,310,228 | SEC↗ |
| Qiming U.S. Healthcare Fund II | Other | P Buy | 2021-08-02 | 2021-08-02 | 200,000 | $15.00 | $3.00M | 3,510,228 | SEC↗ |
| Qiming U.S. Healthcare Fund II | Other | P Buy | 2021-08-02 | 2021-08-02 | 13,333 | $15.00 | $200.0K | 3,523,561 | SEC↗ |
| ADAMS STREET PARTNERS LLC | Other | C Conversion | 2021-08-02 | 2021-08-03 | 525,729 | — | $0 | 525,729 | SEC↗ |
| ADAMS STREET PARTNERS LLC | Other | C Conversion | 2021-08-02 | 2021-08-03 | 948,188 | — | $0 | 948,188 | SEC↗ |
| ADAMS STREET PARTNERS LLC | Other | P Buy | 2021-08-02 | 2021-08-03 | 47,981 | $15.00 | $719.7K | 996,169 | SEC↗ |
| ADAMS STREET PARTNERS LLC | Other | C Conversion | 2021-08-02 | 2021-08-03 | 916,558 | — | $0 | 916,558 | SEC↗ |
| ADAMS STREET PARTNERS LLC | Other | P Buy | 2021-08-02 | 2021-08-03 | 46,381 | $15.00 | $695.7K | 962,939 | SEC↗ |
| ADAMS STREET PARTNERS LLC | Other | P Buy | 2021-08-02 | 2021-08-03 | 12,368 | $15.00 | $185.5K | 256,783 | SEC↗ |
| ADAMS STREET PARTNERS LLC | Other | C Conversion | 2021-08-02 | 2021-08-03 | 244,415 | — | $0 | 244,415 | SEC↗ |
| ADAMS STREET PARTNERS LLC | Other | P Buy | 2021-08-02 | 2021-08-03 | 26,604 | $15.00 | $399.1K | 552,333 | SEC↗ |
| ADAMS STREET PARTNERS LLC | Other | C Conversion | 2021-08-02 | 2021-08-03 | 352,037 | — | $0 | 352,037 | SEC↗ |
| ADAMS STREET PARTNERS LLC | Other | C Conversion | 2021-08-02 | 2021-08-03 | 272,131 | — | $0 | 272,131 | SEC↗ |
| Gould Terry P | Director | P Buy | 2021-08-02 | 2021-08-03 | 47,981 | $15.00 | $719.7K | 996,169 | SEC↗ |
| Gould Terry P | Director | C Conversion | 2021-08-02 | 2021-08-03 | 352,037 | — | $0 | 352,037 | SEC↗ |
| Gould Terry P | Director | C Conversion | 2021-08-02 | 2021-08-03 | 272,131 | — | $0 | 272,131 | SEC↗ |
| Gould Terry P | Director | P Buy | 2021-08-02 | 2021-08-03 | 46,381 | $15.00 | $695.7K | 962,939 | SEC↗ |
| Gould Terry P | Director | C Conversion | 2021-08-02 | 2021-08-03 | 916,558 | — | $0 | 916,558 | SEC↗ |
| Gould Terry P | Director | C Conversion | 2021-08-02 | 2021-08-03 | 525,729 | — | $0 | 525,729 | SEC↗ |
| Gould Terry P | Director | C Conversion | 2021-08-02 | 2021-08-03 | 948,188 | — | $0 | 948,188 | SEC↗ |
| Gould Terry P | Director | P Buy | 2021-08-02 | 2021-08-03 | 12,368 | $15.00 | $185.5K | 256,783 | SEC↗ |
| Gould Terry P | Director | C Conversion | 2021-08-02 | 2021-08-03 | 244,415 | — | $0 | 244,415 | SEC↗ |
| Gould Terry P | Director | P Buy | 2021-08-02 | 2021-08-03 | 26,604 | $15.00 | $399.1K | 552,333 | SEC↗ |
| Cormorant Global Healthcare Ma | Other | C Conversion | 2021-08-02 | 2021-08-04 | 426,393 | — | $0 | 426,393 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | C Conversion | 2021-08-02 | 2021-08-04 | 2,645,779 | — | $0 | 2,645,779 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | P Buy | 2021-08-02 | 2021-08-04 | 2,494,900 | $15.00 | $37.42M | 5,140,679 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | C Conversion | 2021-08-02 | 2021-08-04 | 466,902 | — | $0 | 466,902 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | P Buy | 2021-08-02 | 2021-08-04 | 171,766 | $15.00 | $2.58M | 638,668 | SEC↗ |
| NanoDimension III, L.P. | Other | C Conversion | 2021-08-02 | 2021-08-04 | 2,749,995 | — | $0 | 2,749,995 | SEC↗ |
| NanoDimension III, L.P. | Other | P Buy | 2021-08-02 | 2021-08-04 | 133,334 | $15.00 | $2.00M | 2,883,329 | SEC↗ |
| Russo Thomas Joseph | Chief Financial Officer | A Award | 2021-07-30 | 2021-08-02 | 32,500 | $15.00 | $487.5K | 32,500 | SEC↗ |
| Kanesa-thasan Niranjan | Chief Medical Officer | A Award | 2021-07-30 | 2021-08-02 | 41,500 | $15.00 | $622.5K | 168,656 | SEC↗ |
| Simpson Adam K. | Chief Executive Officer | A Award | 2021-07-30 | 2021-08-02 | 125,000 | $15.00 | $1.88M | 125,000 | SEC↗ |